Michael Czapka

Michael Czapka, MD, is an Assistant Professor in the Department of Medicine-Infectious Diseases at the University of Chicago. He specializes in treating infections in immunocompromised adults, particularly those undergoing organ transplants, chemotherapy, stem cell transplants, and CAR T-cell therapy, with expertise in fungal/viral infections. His work includes clinical trials for novel antimicrobial therapies and hospital quality improvement initiatives.

Dr. Czapka's research focuses on:

• Infectious complications in immunocompromised hosts
• Pathogenesis of fungal/viral infections
• Clinical trial design for novel antimicrobial agents
• CAR T-cell therapy-associated infections
• Ethical frameworks for clinical research

His publications emphasize infectious disease management in high-risk populations, with recent work exploring longitudinal risk modeling in immunotherapy recipients and evolving treatment paradigms for complex infections.